A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
Clinical trial NCT03414229 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03414229
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-23
- Primary completion
- 2024-09-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.